Fundraising FoxOpus KSD
Halifax, US · Delaware corporation
Find your way into Opus KSD
Sign up to see every warm intro you have to Opus KSD
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Opus KSD team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
CH
Charles H RogersExecutive
SA
Saud AlturkiNamed on SEC filing
CM
Christos MonovoukasNamed on SEC filing
WS
Wei ShenNamed on SEC filing
Board
PA
Porter AndersonBoard director
KD
Kenneth DanielsonBoard director
Reported raises · per SEC filings
Form D private placements$1.5M disclosed across 3 rounds · 2016–2026
▶$680.8KraisedOct 2026 · 16 investors · BiotechnologyRule 506(b)
▶$680.8KraisedOct 2026 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Charles RogersDirector
- Saud AlturkiDirector
- Porter AndersonDirector
- Kenneth DanielsonDirector
- Christos MonovoukasDirector
- Wei ShenDirector
- Offering amount
- $680.8K
- Amount sold
- $680.8K
- Minimum investment
- $10K
- First sale
- Sep 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$300KraisedOct 2023 · 3 investors · BiotechnologyRule 506(b)
▶$300KraisedOct 2023 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Porter AndersonDirector
- Saud Abdulaziz al-TurkiDirector
- Wei ShenDirector
- Charles H RogersExecutive Officer, Director
- Kenneth S DanielsonDirector
- Offering amount
- $1M
- Amount sold
- $300K
- Minimum investment
- $50K
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedMar 2016 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedMar 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Charles H RogersExecutive Officer, Director
- Porter AndersonDirector
- Kenneth DanielsonDirector
- Offering amount
- $1M
- Amount sold
- $500K
- Minimum investment
- $1K
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
MerilMeril designs and manufactures medical devices across areas including vascular and peripheral intervention, cardiac surgery, orthopedics, endo-surgery, ENT, urology, diagnostics, and surgical robotics for hospitals, clinicians, and surgeons. Its products are made in-house in India and distributed internationally, with its ENT line present in more than 50 countries.
Companies working in the same space as Opus KSD.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2015 | $752.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $147.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- How much funding has Opus KSD raised?
- Opus KSD has disclosed $1.5M raised across 3 rounds.
- Where is Opus KSD headquartered?
- Opus KSD is headquartered in Halifax, US.